BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 78 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 9.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $348,000 | +47.5% | 17,500 | -4.0% | 0.02% | +16.7% |
| Q2 2016 | $236,000 | -16.0% | 18,225 | -39.2% | 0.02% | +50.0% |
| Q1 2016 | $281,000 | -45.6% | 30,000 | +17.6% | 0.01% | -66.7% |
| Q4 2015 | $517,000 | +73.5% | 25,500 | +24.4% | 0.04% | +176.9% |
| Q3 2015 | $298,000 | -74.3% | 20,500 | -59.0% | 0.01% | -74.5% |
| Q1 2015 | $1,159,000 | +0.6% | 50,000 | 0.0% | 0.05% | +27.5% |
| Q4 2014 | $1,152,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |